Article
Author(s):
San Francisco - The known teratogenicity of isotretinoin, as well as a possible link to psychiatric illness, means that physicians prescribing the drug must carefully follow risk-management guidelines. These guidelines are mandated by the FDA.
Addressing Challenging Cases of Acne: Part 3
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Hyperpigmentation: Is It Medical or Cosmetic?
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Vivian Shi, MD: Creative Approaches to Eczema Care
Elevate-Derm Previews Upcoming West Coast Conference and Dermoscopy Sessions